RecruitingNCT03883711
Acute Myocardial Infarction: Prognostic and Therapeutic Evaluation
Acute Myocardial Infarction From Clinical Presentation to Strategy Treatment
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
11,000 participants
Start Date
Jan 1, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
AMIPE is both a retrospective and prospective study which was designed in order to collect data of patients with acute coronary syndromes and myocardial injury and to improve the knowledge about these conditions.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patient aged > 18 years old
- Acute coronary syndrome or myocardial injury
- Written informed consent
Exclusion Criteria1
- under age or not able to give informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERDatabase
Create a database containing clinical characteristic, clinical presentation, flow indexes and treatment of consecutive incident patients with ACS or myocardial injury.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03883711
Related Trials
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
NCT072582901 location
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
NCT046951061 location
Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS
NCT060141129 locations
Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis
NCT054735206 locations
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
NCT0710262860 locations